Radium-223 treatment did not seem to significantly reduce the risk of symptomatic pathological bone fracture ( HR 062 , 95 % CI 035-109 ) , or the need for tumour-related orthopaedic surgical intervention ( HR 072 , 95 % CI 028-182 ) .